Avalo Therapeutics (AVTX) EBITDA Margin Growth (1y) (2017 - 2025)
Avalo Therapeutics (AVTX) EBITDA Margin Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-480,275.00 |
| Dec 31, 2024 |
-1.71 Mn |
| Sep 30, 2024 |
1.15 Mn |
| Dec 31, 2023 |
-35,287.00 |
| Sep 30, 2023 |
-223,661.00 |
| Jun 30, 2023 |
-1,697.00 |
| Mar 31, 2023 |
-21,591.00 |
| Dec 31, 2022 |
721,400.00 |
| Sep 30, 2022 |
124,083.00 |
| Jun 30, 2022 |
-74,666.00 |
| Mar 31, 2022 |
458,524.00 |
| Dec 31, 2021 |
-711,083.00 |
| Sep 30, 2021 |
-2,443.00 |
| Jun 30, 2021 |
37,248.00 |
| Mar 31, 2021 |
-532,448.00 |
| Dec 31, 2020 |
-10,613.00 |
| Sep 30, 2020 |
-106,505.00 |
| Jun 30, 2020 |
-69,998.00 |
| Mar 31, 2020 |
-94,637.00 |
| Dec 31, 2019 |
-101,000.00 |
